Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses.

The recent outbreaks of Ebolavirus (EBOV) in West Africa underscore the urgent need to develop an effective EBOV vaccine. Here, we report the development of synthetic nanoparticles as a safe and highly immunogenic platform for vaccination against EBOV. We show that a large recombinant EBOV antigen (...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nanomedicine
Main Authors: Bazzill, Joseph D., Stronsky, Sabrina M., Kalinyak, Laura C., Ochyl, Lukasz J., Steffens, Jesse T., van Tongeren, Sean A., Cooper, Christopher L., Moon, James J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531357/
https://ncbi.nlm.nih.gov/pubmed/30471480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2018.11.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados